Terug
Dagbereik
€ 28,90
€ 30,33
52-Weeksbereik
€ 10,60
€ 31,82
Volume
696.023
50D / 200D Gem.
€ 28,95
/
€ 19,99
Vorige Slotkoers
€ 29,06
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -19,1 | 0,4 |
| P/B | 6,1 | 2,9 |
| ROE % | -34,2 | 3,7 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 38,67
+29.8%
Low: € 25,00
High: € 46,00
Forward WPA
-€ 2,09
Omzet Sch.
2,3 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,31
€ 0,61 – € 2,30
|
780 M | 5 |
| FY2029 |
-€ 0,77
-€ 1,35 – -€ 0,36
|
340 M | 2 |
| FY2028 |
-€ 1,72
-€ 2,31 – -€ 1,20
|
130 M | 7 |
Belangrijkste Punten
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -143,82M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-34,19%
ROIC-27,28%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,01
Current Ratio19,85
Interest Coverage0,00
Waardering
P/E Ratio
-19,05
P/B Ratio6,12
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -167,80M |
| ROE | -34,19% | ROA | -30,36% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -143,82M |
| ROIC | -27,28% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 19,85 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -19,05 | P/B Ratio | 6,12 |
| P/S Ratio | N/A | PEG Ratio | -1,23 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 3,20B | Enterprise Value | 3,14B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -167,80M | -133,81M | -100,16M | -67,64M | -42,81M |
| EPS (Diluted) | -1,63 | -1,45 | -1,57 | -1,26 | -0,86 |
| Gross Profit | -2,27M | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -191,41M | -158,83M | -114,36M | -71,66M | -43,22M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 552,60M | 486,82M | 340,04M | 367,10M | 285,23M |
| Total Liabilities | 30,35M | 27,60M | 21,21M | 20,39M | 10,85M |
| Shareholders' Equity | 522,26M | 459,22M | 318,83M | 346,72M | 274,38M |
| Total Debt | 3,99M | 4,74M | 5,41M | 4,41M | 0,0 |
| Cash & Equivalents | 61,15M | 41,67M | 86,10M | 21,99M | 15,57M |
| Current Assets | 543,39M | 475,48M | 327,00M | 357,00M | 283,77M |
| Current Liabilities | 27,37M | 23,86M | 16,77M | 16,59M | 10,52M |